Adherence Improvement in Glaucoma Patients

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00603005

Enrollment

802

Registered

2008-01-28

Start date

2007-10-31

Completion date

2010-01-31

Last updated

2010-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Keywords

Glaucoma, Adherence

Brief summary

The purpose of this study is to study the effect on intraocular pressure in glaucoma patients using the TravAlert dosing aid with or without the Eyot drop guider and with or without additional patient education.

Interventions

DEVICEUse of TravAlert dosing aid with or without drop guider

Each patient will use a dosing aid and/or drop guider for 6 months

Study design

Allocation

RANDOMIZED

Intervention model

FACTORIAL

Primary purpose

SUPPORTIVE_CARE

Masking

SINGLE (Caregiver)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Diagnosis glaucoma or ocular hypertension * Treatment with travoprost or travoprost/timolol

Exclusion criteria

* High risk of side effects expected from travoprost or travoprost/timolol * Absolute inability to administer eye drops * Difficulty in reading or speaking Dutch

Design outcomes

Primary

Measure	Time frame
Intraocular pressure	6 months

Secondary

Measure	Time frame
Information with regard to the use of eye drops from data generated by the TravAlert dosing system	6 months

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026